Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110


Infiltrating T cells promote prostate cancer metastasis via modulation of FGF11→miRNA-541→androgen receptor (AR)→MMP9 signaling.

Hu S, Li L, Yeh S, Cui Y, Li X, Chang HC, Jin J, Chang C.

Mol Oncol. 2015 Jan;9(1):44-57. doi: 10.1016/j.molonc.2014.07.013. Epub 2014 Jul 29. Erratum in: Mol Oncol. 2016 Dec;10 (10 ):1628-1629. Mol Oncol. 2016 Dec;10 (10 ):1628-1629.


Infiltrated pre-adipocytes increase prostate cancer metastasis via modulation of the miR-301a/androgen receptor (AR)/TGF-β1/Smad/MMP9 signals.

Xie H, Li L, Zhu G, Dang Q, Ma Z, He D, Chang L, Song W, Chang HC, Krolewski JJ, Nastiuk KL, Yeh S, Chang C.

Oncotarget. 2015 May 20;6(14):12326-39. Erratum in: Oncotarget. 2016 Dec 13;7(50):83829-83830.


Anti-androgen enzalutamide enhances prostate cancer neuroendocrine (NE) differentiation via altering the infiltrated mast cells → androgen receptor (AR) → miRNA32 signals.

Dang Q, Li L, Xie H, He D, Chen J, Song W, Chang LS, Chang HC, Yeh S, Chang C.

Mol Oncol. 2015 Aug;9(7):1241-51. doi: 10.1016/j.molonc.2015.02.010. Epub 2015 Mar 5.


Tumor microenvironment B cells increase bladder cancer metastasis via modulation of the IL-8/androgen receptor (AR)/MMPs signals.

Ou Z, Wang Y, Liu L, Li L, Yeh S, Qi L, Chang C.

Oncotarget. 2015 Sep 22;6(28):26065-78. doi: 10.18632/oncotarget.4569.


Differential androgen deprivation therapies with anti-androgens casodex/bicalutamide or MDV3100/Enzalutamide versus anti-androgen receptor ASC-J9(R) Lead to promotion versus suppression of prostate cancer metastasis.

Lin TH, Lee SO, Niu Y, Xu D, Liang L, Li L, Yeh SD, Fujimoto N, Yeh S, Chang C.

J Biol Chem. 2013 Jul 5;288(27):19359-69. doi: 10.1074/jbc.M113.477216. Epub 2013 May 16.


Infiltrating bone marrow mesenchymal stem cells increase prostate cancer stem cell population and metastatic ability via secreting cytokines to suppress androgen receptor signaling.

Luo J, Ok Lee S, Liang L, Huang CK, Li L, Wen S, Chang C.

Oncogene. 2014 May 22;33(21):2768-78. doi: 10.1038/onc.2013.233. Epub 2013 Jun 24.


Infiltrating bone marrow mesenchymal stem cells (BM-MSCs) increase prostate cancer cell invasion via altering the CCL5/HIF2α/androgen receptor signals.

Luo J, Lee SO, Cui Y, Yang R, Li L, Chang C.

Oncotarget. 2015 Sep 29;6(29):27555-65. doi: 10.18632/oncotarget.4515.


Infiltrating T Cells Promote Bladder Cancer Progression via Increasing IL1→Androgen Receptor→HIF1α→VEGFa Signals.

Tao L, Qiu J, Jiang M, Song W, Yeh S, Yu H, Zang L, Xia S, Chang C.

Mol Cancer Ther. 2016 Aug;15(8):1943-1951. doi: 10.1158/1535-7163.MCT-15-0306. Epub 2016 May 11.


Androgen receptor (AR) suppresses miRNA-145 to promote renal cell carcinoma (RCC) progression independent of VHL status.

Chen Y, Sun Y, Rao Q, Xu H, Li L, Chang C.

Oncotarget. 2015 Oct 13;6(31):31203-15. doi: 10.18632/oncotarget.4522.


Endothelial cells enhance prostate cancer metastasis via IL-6→androgen receptor→TGF-β→MMP-9 signals.

Wang X, Lee SO, Xia S, Jiang Q, Luo J, Li L, Yeh S, Chang C.

Mol Cancer Ther. 2013 Jun;12(6):1026-37. doi: 10.1158/1535-7163.MCT-12-0895. Epub 2013 Mar 27.


Regulation and methylation of tumor suppressor miR-124 by androgen receptor in prostate cancer cells.

Chu M, Chang Y, Guo Y, Wang N, Cui J, Gao WQ.

PLoS One. 2015 Apr 10;10(4):e0116197. doi: 10.1371/journal.pone.0116197. eCollection 2015.


Targeting the androgen receptor with siRNA promotes prostate cancer metastasis through enhanced macrophage recruitment via CCL2/CCR2-induced STAT3 activation.

Izumi K, Fang LY, Mizokami A, Namiki M, Li L, Lin WJ, Chang C.

EMBO Mol Med. 2013 Sep;5(9):1383-401. doi: 10.1002/emmm.201202367. Epub 2013 Aug 27.


Amino-terminal enhancer of split gene AES encodes a tumor and metastasis suppressor of prostate cancer.

Okada Y, Sonoshita M, Kakizaki F, Aoyama N, Itatani Y, Uegaki M, Sakamoto H, Kobayashi T, Inoue T, Kamba T, Suzuki A, Ogawa O, Taketo MM.

Cancer Sci. 2017 Apr;108(4):744-752. doi: 10.1111/cas.13187. Epub 2017 Apr 12.


C1QBP Regulates YBX1 to Suppress the Androgen Receptor (AR)-Enhanced RCC Cell Invasion.

Yue D, Wang Y, Sun Y, Niu Y, Chang C.

Neoplasia. 2017 Feb;19(2):135-144. doi: 10.1016/j.neo.2016.12.003. Epub 2017 Jan 17.


miR-1207-3p regulates the androgen receptor in prostate cancer via FNDC1/fibronectin.

Das DK, Naidoo M, Ilboudo A, Park JY, Ali T, Krampis K, Robinson BD, Osborne JR, Ogunwobi OO.

Exp Cell Res. 2016 Nov 1;348(2):190-200. doi: 10.1016/j.yexcr.2016.09.021. Epub 2016 Sep 29.


Targeting TR4 nuclear receptor suppresses prostate cancer invasion via reduction of infiltrating macrophages with alteration of the TIMP-1/MMP2/MMP9 signals.

Ding X, Yang DR, Xia L, Chen B, Yu S, Niu Y, Wang M, Li G, Chang C.

Mol Cancer. 2015 Jan 27;14:16. doi: 10.1186/s12943-014-0281-1.


Increased PrLZ-mediated androgen receptor transactivation promotes prostate cancer growth at castration-resistant stage.

Li L, Xie H, Liang L, Gao Y, Zhang D, Fang L, Lee SO, Luo J, Chen X, Wang X, Chang LS, Yeh S, Wang Y, He D, Chang C.

Carcinogenesis. 2013 Feb;34(2):257-67. doi: 10.1093/carcin/bgs337. Epub 2012 Oct 26.


Androgen receptor promotes melanoma metastasis via altering the miRNA-539-3p/USP13/MITF/AXL signals.

Wang Y, Ou Z, Sun Y, Yeh S, Wang X, Long J, Chang C.

Oncogene. 2017 Mar 23;36(12):1644-1654. doi: 10.1038/onc.2016.330. Epub 2016 Nov 21.


Androgen receptor (AR) promotes clear cell renal cell carcinoma (ccRCC) migration and invasion via altering the circHIAT1/miR-195-5p/29a-3p/29c-3p/CDC42 signals.

Wang K, Sun Y, Tao W, Fei X, Chang C.

Cancer Lett. 2017 May 28;394:1-12. doi: 10.1016/j.canlet.2016.12.036. Epub 2017 Jan 13.


Supplemental Content

Support Center